1. Home
  2. RELL vs SKYE Comparison

RELL vs SKYE Comparison

Compare RELL & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

HOLD

Current Price

$17.51

Market Cap

248.1M

Sector

Technology

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$1.68

Market Cap

9.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELL
SKYE
Founded
1947
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.1M
9.0M
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
RELL
SKYE
Price
$17.51
$1.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
★ 93.8K
81.8K
Earning Date
04-08-2026
05-08-2026
Dividend Yield
★ 1.75%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $228,564,000.00
N/A
Revenue This Year
$6.32
N/A
Revenue Next Year
$7.91
N/A
P/E Ratio
$230.96
★ N/A
Revenue Growth
★ 9.41
N/A
52 Week Low
$9.37
$0.26
52 Week High
$23.15
$4.99

Technical Indicators

Market Signals
Indicator
RELL
SKYE
Relative Strength Index (RSI) 51.57 50.51
Support Level $16.40 $1.57
Resistance Level $17.94 $2.28
Average True Range (ATR) 0.60 0.23
MACD 0.13 -0.08
Stochastic Oscillator 84.16 16.00

Price Performance

Historical Comparison
RELL
SKYE

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: